Treatment with diphenyl-pyrazole compound anle138b/c reveals that 
alpha-synuclein protects melanoma cells from autophagic cell death

Turriani, Elisa; Lázaro, Diana F.; Ryazanov, Sergey; Leonov, Andrei; Giese, Armin; Schön, Margarete; Schön, Michael P.; Griesinger, Christian; Outeiro, Tiago F.; Arndt-Jovin, Donna; Becker, Dorothea

doi:10.1073/pnas.1700200114

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Treatment with diphenyl-pyrazole compound anle138b/c reveals that alpha-synuclein protects melanoma cells from autophagic cell death

MPS-Authors

/persons/resource/persons197309

Outeiro, Tiago F.
Experimental Neurodegeneration, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Turriani, E., Lázaro, D. F., Ryazanov, S., Leonov, A., Giese, A., Schön, M., et al. (2017). Treatment with diphenyl-pyrazole compound anle138b/c reveals that alpha-synuclein protects melanoma cells from autophagic cell death. Proceedings of the National Academy of Sciences of the United States of America, 114(25), E4971-E4977. doi:10.1073/pnas.1700200114.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-C48A-A

Abstract

There is no abstract available